Tytuł pozycji:
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
-
Tytuł:
-
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
-
Autorzy:
-
Kuemmel, SherkoAff1, Aff2
Tondini, Carlo A.
Abraham, Jacinta
Nowecki, Zbigniew
Itrych, BartoszAff6, Aff18
Hitre, Erika
Karaszewska, Bogusława
Juárez-Ramiro, Alejandro
Morales-Vásquez, Flavia
Pérez-García, Jose ManuelAff11, Aff19
Cardona-Huerta, Servando
Monturus, Estefania
Sequi, MarcoAff14, Aff15
Restuccia, Eleonora
Benyunes, Mark
Martín, Miguel
-
Źródło:
-
Breast Cancer Research and Treatment. 187(2):467-476
-